2008 Full Year Guidance
Based on current market and operating conditions, we raise our total net revenue target for the full year 2008 from US$30 to US$32 million to US$34 to US$35 million.
3SBio senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on Wednesday, August 13, 2008 to discuss its 2008 second quarter financial results and recent business activity. The conference call may be accessed by calling (US) +1 480 629 9041 / (UK) +44 (0) 20 8515 2301 / (HK) +852 3009 5027. A telephone replay will be available shortly after the call until August 27, 2008 at (US) +1 303 590 3030/ (UK) +44 (0)20 7154 2833, Passcode: 3906839; and (HK) +852 2287 4304, Passcode: 098110#. A live webcast of the conference call and replay will be available on the investor relations page of 3SBio's website at http://bbs.3sbio.com/en/News/ShowInfo_nnn5.aspx?ID=64 .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com .
Safe Harbor Statement
Statements in this release may contain "forward-looking" statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, and as defined in the Private Securities Litigation Reform Act of
|SOURCE 3SBio Inc.|
Copyright©2008 PR Newswire.
All rights reserved